In one of his last official acts in office, President Biden selected semaglutide—the active ingredient in Novo Nordisk’s GLP-1 drugs Wegovy, Ozempic and Rybelsus—for Medicare drug price negotiations.
Strategist | strategy-catalyst
Biden selects Novo Nordisk’s GLP-1 drugs for Medicare price negotiation
Related Topics:
Health Policy and Advocacy Relevant Roles:
Chief Strategy Officers